title: Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Rose
authors.forename: A Bruce
authors.initials: AB
authors.lastname: Montgomery
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D019141:Respiratory System Agents / Q000627:therapeutic use*
chemical_list: D019141:Respiratory System Agents